Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Psychosomatic Research

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpsychores.2018.02.012PMID 29602320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review

  2017cited by this paper
• Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014

  2017cited by this paper
• Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer

  2017cited by this paper
• Hyperacute peripheral neuropathy is a predictor of oxaliplatin-induced persistent peripheral neuropathy

  2017cited by this paper
• Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study

  2016cited by this paper
• Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk

  2016cited by this paper
• Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.

  2015cited by this paper
• Global Cancer Incidence and Mortality Rates and Trends—An Update

  2015cited by this paper
• Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

  2015cited by this paper
• Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

  2014cited by this paper
• Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

  2013cited by this paper
• Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

  2013cited by this paper
• The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

  2013cited by this paper
• Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review.

  2013cited by this paper
• Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.

  2012cited by this paper
• Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

  2012cited by this paper
• Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy.

  2012cited by this paper
• Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy

  2011cited by this paper
• Risk of Chemotherapy-Induced Peripheral Neuropathy in Large Population-Based Cohorts of Elderly Patients With Breast, Ovarian, and Lung Cancer

  2010cited by this paper
• NCCN task force report: management of neuropathy in cancer.

  2009cited by this paper
• Pain Catastrophizing Mediates the Relationship Between Self-Reported Strenuous Exercise Involvement and Pain Ratings: Moderating Role of Anxiety Sensitivity

  2009cited by this paper
• Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.

  2008cited by this paper
• Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

  2008cited by this paper
• Chemotherapy‐induced neuropathy

  2008cited by this paper
• Tendency to Catastrophize Somatic Sensations: Pain Catastrophizing and Anxiety Sensitivity in Predicting Headache

  2006cited by this paper
• The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey

  2005cited by this paper
• Toxic neuropathy in patients with pre-existing neuropathy

  2003cited by this paper
• The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

  2002cited by this paper
• Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

  2002cited by this paper
• An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.

  2002cited by this paper
• The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

  1998cited by this paper
• Psychometric evaluation of the Pittsburgh Sleep Quality Index.

  1998cited by this paper
• Neuroanatomy of the pain system and of the pathways that modulate pain.

  1997cited by this paper
• Neurotoxicity of Taxol.

  1993cited by this paper
• The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

  1989cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper

• Incidence and influencing factors of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis

  2026cites this paper
• Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathy

  2026cites this paper
• Coasting related to taxane-induced peripheral neuropathy in patients with breast cancer: a systematic review

  2025cites this paper
• Long-term quality of life in non-epithelial ovarian cancer survivors: TMRG-GINECO-Vivrovaire rare tumors case–control study

  2025cites this paper
• Associations Between Chemotherapy-Induced Peripheral Neuropathy and Distress in Patients Assigned to Adjuvant Irradiation for Non-Metastatic Breast Cancer

  2025cites this paper
• Psychological distress and coping strategies in breast cancer patients under neoadjuvant therapy: A systematic review

  2024cites this paper
• Manajemen nyeri dengan virtual reality therapy pada pasien kanker : studi kasus

  2024cites this paper
• A red cell membrane-camouflaged nanoreactor for enhanced starvation/chemodynamic/ion interference therapy for breast cancer.

  2024cites this paper
• Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study

  2024cites this paper
• An evaluation of the effect of lithium on taxane-induced neuropathy

  2023cites this paper
• The effect of cognitive behavioral therapy on chemotherapy-induced side effects and immune function in colorectal cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial

  2023cites this paper
• Anxiety in oncology outpatients is associated with perturbations in pathways identified in anxiety focused network pharmacology research

  2023cites this paper
• Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis

  2023cites this paper
• Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer

  2023cites this paper
• Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review

  2023cites this paper
• Prevalence of depression and anxiety among patients with breast cancer: a cross-sectional study

  2022cites this paper
• Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

  2022cites this paper
• Symptoms of pre-treatment anxiety are associated with the development of chronic peripheral neuropathy among colorectal cancer patients

  2022influential citation
• Sociodemographic, Clinical, Lifestyle, and Psychological Correlates of Peripheral Neuropathy among 2- to 12-Year Colorectal Cancer Survivors

  2022cites this paper
• The longitudinal effects of chronotype on chemotherapy-induced nausea and vomiting in patients with breast cancer receiving neoadjuvant chemotherapy.

  2022cites this paper
• The long-awaited EAPM 2022 meeting in Vienna.

  2022cites this paper
• Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer

  2022cites this paper
• Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients

  2022cites this paper
• Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming

  2022cites this paper
• AAAPT Diagnostic Criteria for Acute Neuropathic Pain.

  2021cites this paper
• Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review

  2021cites this paper
• Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Longitudinal study of Inflammatory, Behavioral, Clinical and Psychosocial Risk Factors for Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy

  2021influential citation
• The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis

  2021cites this paper
• Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer

  2021cites this paper
• Recent advances in understanding chemotherapy-induced peripheral neuropathy

  2020cites this paper
• Taxane-induced peripheral neuropathy: differences in patient report and objective assessment

  2020cites this paper
• Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry

  2020cites this paper
• Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer

  2020cites this paper
• The Association Between the Incidence Risk of Peripheral Neuropathy and PD-1/PD-L1 Inhibitors in the Treatment for Solid Tumor Patients: A Systematic Review and Meta-Analysis

  2019cites this paper
• Anxiety and depression mediate the association between chemotherapy‐induced peripheral neuropathy and fatigue: Results from the population‐based PROFILES registry

  2019cites this paper
• Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer

  2019cites this paper
• The Effects of Positive Psychological Interventions on Medical Patients' Anxiety: A Meta-Analysis.

  2019cites this paper
• Journal of Psychosomatic Research Editor's Year in Review.

  2019cites this paper
• The effect of perceived social support on chemotherapy-related symptoms in patients with breast cancer: A prospective observational study.

  2019cites this paper
• The efficacy of virtual reality for persistent cancer pain: A call for research.

  2019cites this paper
• Taxane and epothilone‐induced peripheral neurotoxicity: From pathogenesis to treatment

  2019cites this paper
• miR‐205‐3p promotes proliferation and reduces apoptosis of breast cancer MCF‐7 cells and is associated with poor prognosis of breast cancer patients

  2019cites this paper
• Molecular subtypes might affect chemotherapy-induced peripheral neuropathy in breast cancer patients receiving neoadjuvant chemotherapy.

  2018cites this paper